End-of-day quote
Other stock markets
|
||
- USD | - |
May. 09 | HLS Therapeutics Meets Q1 Earnings Forecast, But Misses on Revs; Lowers 2024 Vascepa Guidance | MT |
May. 08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
Chart calendar Pfizer Inc
Upcoming events on Pfizer Inc
Past events on Pfizer Inc
2024-05-08 | Ex-dividend day |
2024-05-01 10:00 am | Q1 2024 Earnings Call |
2024-05-01 06:45 am | Q1 2024 Earnings Release |
2024-04-25 09:00 am | Annual General Meeting |
2024-03-12 08:00 am | Leerink Partners Global Biopharma Conference |
2024-03-04 11:10 am | TD Cowen Health Care Conference |
2024-02-29 01:00 pm | Investor Day - Oncology Innovation |
2024-01-30 10:00 am | Q4 2023 Earnings Call |
2024-01-30 06:45 am | Q4 2023 Earnings Release |
2024-01-24 | Ex-dividend day |
2024-01-08 06:00 pm | JPMorgan Healthcare Conference |
2023-12-13 08:30 am | Q4 2024 Guidance Call |
2023-12-11 08:15 pm | American Society of Hematology Meeting - Abstract Number -1054 |
2023-12-11 07:30 pm | American Society of Hematology Meeting - Abstract Number -1057 |
2023-12-09 07:45 pm | American Society of Hematology Meeting - Abstract Number -274 |
2023-12-09 07:30 pm | American Society of Hematology Meeting - Abstract Number -285 |
2023-12-09 12:45 pm | American Society of Hematology Meeting - Abstract Number -14 |
2023-11-28 10:50 am | Evercore ISI HealthCONx Conference |
2023-11-09 12:35 pm | Truist Securities Healthcare Conference |
2023-11-08 | Ex-dividend day |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 51 750 51 807 -0.11% | 41 908 48 014 -12.72% | 81 288 81 781 -0.6% | 100 330 100 373 -0.04% | 58 496 59 105 -1.03% | 60 407 |
EBITDA Million USD | Released Forecast Spread | 21 097 22 824 -7.57% | 17 801 21 398 -16.81% | 25 426 29 444 -13.65% | 42 336 44 597 -5.07% | 15 590 11 249 38.59% | 21 189 |
EBIT Million USD | Released Forecast Spread | 19 420 19 883 -2.33% | 13 024 17 362 -24.99% | 20 235 26 662 -24.11% | 37 272 40 403 -7.75% | 9 300 8 509 9.3% | 17 050 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 17 682 22 426 -21.15% | 7 497 13 166 -43.06% | 24 311 19 569 24.23% | 34 729 39 058 -11.08% | 1 058 2 301 -54.02% | 11 020 |
Net income Million USD | Released Forecast Spread | 16 273 19 053 -14.59% | 9 616 16 066 -40.15% | 21 979 22 567 -2.6% | 31 372 33 053 -5.09% | 2 119 3 040 -30.29% | 7 775 |
EPS USD | Released Forecast Spread | 2,87 3,40 -15.62% | 1,71 3,07 -44.24% | 3,85 3,89 -0.9% | 5,47 5,85 -6.45% | 0,37 0,72 -48.44% | 1,44 |
Announcement Date | 28/01/20 | 02/02/21 | 08/02/22 | 31/01/23 | 30/01/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 25 661 24 734 3.75% | 27 742 26 199 5.89% | 22 638 21 091 7.33% | 24 290 24 393 -0.42% | 18 282 16 488 10.88% | 12 734 13 398 -4.96% | 13 232 13 429 -1.47% | 14 249 14 396 -1.02% | 14 879 13 923 6.87% | 13 050 | 14 847 | 17 770 | 15 680 | 13 725 |
EBITDA Million USD | Released Forecast Spread | 11 135 13 710 -18.78% | 13 583 12 434 9.25% | 10 325 10 332 -0.06% | 6 772 7 436 -8.92% | 7 857 7 513 4.58% | 4 925 4 000 23.13% | -1 244 -1 511 17.64% | 1 340 -1 298 203.24% | 4 403 | 3 759 | 4 681 | 4 537 | ||
EBIT Million USD | Released Forecast Spread | 9 948 9 738 2.16% | 12 408 11 055 12.24% | 9 142 9 092 0.55% | 5 253 6 886 -23.71% | 6 370 6 471 -1.56% | 3 319 3 634 -8.68% | -1 625 -1 827 11.07% | -330 -1 404 76.5% | 5 912 3 667 61.24% | 3 423 | 3 804 | 3 977 | ||
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 9 050 | 5 231 7 425 -29.55% | -3 352 2 207 -251.88% | -4 129 -3 139 -31.54% | 3 421 2 992 14.34% | 1 962 | 2 926 | 3 380 | ||||||
Net income Million USD | Released Forecast Spread | 7 864 8 418 -6.58% | 9 906 9 799 1.09% | 8 608 7 631 12.8% | 4 995 5 667 -11.86% | 5 543 4 495 23.31% | 2 327 | -2 382 -3 241 26.49% | -3 369 -2 371 -42.12% | 3 115 1 951 59.69% | 1 496 | 2 046 | 2 679 | ||
EPS USD | Released Forecast Spread | 1,37 1,60 -14.17% | 1,73 1,64 5.73% | 1,51 1,37 10.21% | 0,87 0,69 25.48% | 0,97 0,85 14.79% | 0,41 | -0,42 -0,51 16.83% | -0,60 -0,43 -41.06% | 0,55 0,34 61.01% | 0,25 | 0,36 | 0,47 | ||
Announcement Date | 03/05/22 | 28/07/22 | 01/11/22 | 31/01/23 | 02/05/23 | 01/08/23 | 31/10/23 | 30/01/24 | 01/05/24 | - | - | - | - | - |
Past sector events for Pfizer Inc
2024-05-10 11:01 am | PIRAMAL PHARMA LIMITED: Q4 2024 Earnings Release |
2024-05-10 06:50 am | ANI PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
2024-05-10 06:46 am | NEULAND LABORATORIES LIMITED: Q4 2024 Earnings Release |
2024-05-09 | NIPPON SHINYAKU CO., LTD.: Q4 2023 Earnings Release |
2024-05-09 | KYORIN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
2024-05-09 | JCR PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release |
2024-05-09 | TTY BIOPHARM COMPANY LIMITED: Q1 2024 Earnings Release (Projected) |
2024-05-09 04:02 pm | COLLEGIUM PHARMACEUTICAL, INC.: Q1 2024 Earnings Release |
2024-05-09 09:58 am | SCINOPHARM TAIWAN, LTD.: April 2024 Sales and Revenue Release |
2024-05-09 09:06 am | ABBOTT INDIA LIMITED: Q4 2024 Earnings Release |
- Stock Market
- Equities
- PFE Stock
- Stock
- Calendar Pfizer Inc